Publicaciones científicas

Intraoperative radiotherapy in locally advanced recurrent colorectal cancer

Abuchaibe O, Calvo FA, Azinovic I, Aristu J, Pardo F, Alvarez-Cienfuegos J.
Oncology Department, Clínica Universitaria de Navarra, Pamplona, Spain

Revista: International Journal of Oncology, Biology, Physics

Fecha: 01-ago-1993

Cirugía General y Digestiva Oncología Radioterápica

PURPOSE
In an effort to promote local control and improve quality of life in patients with recurrent colorectal cancer, a multimodality approach has been used.

METHODS AND MATERIALS
Twenty-seven patients were treated with moderate doses of pre/postoperative radiotherapy with/without simultaneous systemic chemotherapy, surgical re-resection and IORT electron boost over areas at high risk for local recurrence.

RESULTS
The 2-year actuarial disease-free and local relapse-free survival for the entire group were 14% and 26%, respectively. The most important factor predicting a favorable outcome was the radicality of surgical procedure. The determinate local control rate and the actuarial 2-year local relapse-free, and disease-free survival for patients undergoing complete resections were 50%, 56%, and 34%, respectively, whereas for patients undergoing partial resections these figures were 16%, 13%, and 6%. The radicality of surgical procedure was influenced by both tumoral size and previous treatment with irradiation. Complete resection rate was higher in patients with tumors less than 5 cm vs. more than 5 cm (40% vs. 22%), and in patients without previous radiotherapy versus those with previous radiotherapy (40% vs. 28%). Distant metastasis rate was high (41%). The most significant toxicities attributable to the whole treatment protocol were enteritis (37%), hydronephrosis (30%), and pelvic neuropathy (52%).

CONCLUSION
Currently, our policy is to recommend IORT in patients with favorable factors such as: absence of previous pelvic radiotherapy, single previous surgical procedure, and complete resections.

CITA DEL ARTÍCULO Int J Radiat Oncol Biol Phys. 1993 Aug 1;26(5):859-67.

tal vezLE INTERESE

¿QUÉ TECNOLOGÍA UTILIZAMOS?

La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

NUESTROS
PROFESIONALES

Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.

Imagen profesionales de la Clínica Universidad de Navarra

POR QUÉ VENIR
A LA CLÍNICA

Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.

Imagen del edificio de la Clínica Universidad de Navarra